It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Japan to shorten booster shot interval for medical workers and seniors on omicron concerns

National Dec 18, 2021

Japan to shorten booster shot interval for medical workers and seniors on omicron concerns

by Kazuaki Nagata

The interval between second shots and booster shots will be six months for health care workers and those living in nursing homes, the prime minister said.

Safety and security are key to a new Go To Travel campaign

Editorials Dec 17, 2021

Safety and security are key to a new Go To Travel campaign

The prospect of a recovery from COVID-19 and a vaccine and pills that can protect against future infection has prompted the Kishida government to restart the Go To Travel program.

Pfizer will dominate $20 billion COVID-19 pill market in 2022, analysis shows

Business Dec 17, 2021

Pfizer will dominate $20 billion COVID-19 pill market in 2022, analysis shows

by James Paton

Demand for the medications is poised to outpace supply as COVID-19 spreads around the globe and scientists question how well vaccines and antibody treatments will hold up against omicron.

Omicron should be a wake-up call for the world

Commentary / World Dec 16, 2021

Omicron should be a wake-up call for the world

Almost no low-income countries are on track to meet the World Health Organization’s goal of vaccinating 40% of their populations by the end of this year.

Omicron scrambles what we know about immunity

Commentary / World Dec 15, 2021

Omicron scrambles what we know about immunity

by Faye Flam

If this thing keeps growing exponentially and infects millions of people in a short time, health systems could collapse, even if a tinier fraction of cases are serious.

Pfizer says COVID-19 pill near 90% protective against hospitalization and death

World Dec 15, 2021

Pfizer says COVID-19 pill near 90% protective against hospitalization and death

Recent lab data suggests the drug retains its effectiveness against the fast spreading omicron variant of the coronavirus.

Japan researchers use ostrich cells to make glowing COVID-19 detection masks

National / Science & Health Dec 10, 2021

Japan researchers use ostrich cells to make glowing COVID-19 detection masks

The discovery could help advance low-cost, at-home testing, and may potentially help those suffering from allergies and other ailments.

How the U.S. can rein in skyrocketing drug prices

Commentary / World Dec 8, 2021

How the U.S. can rein in skyrocketing drug prices

Negotiated prices on many medications would introduce an important new form of cost control in uncompetitive corners of the U.S. prescription-drug market.

New COVID-19 pills offer hope as omicron looms

World / Science & Health Dec 7, 2021

New COVID-19 pills offer hope as omicron looms

by Carl Zimmer

Two new antiviral pills are coming soon, and are expected to work against all versions of the virus.

Who’s afraid of evidence-based policymaking?

Commentary / World Dec 5, 2021

Who’s afraid of evidence-based policymaking?

by Ori Heffetz and John A. List

As societies struggle to reopen in the shadow of new COVID-19 variants, social experiments are urgently needed to ensure that we implement policies with proven records of success.

Six vaccines show promise as boosters, led by mRNA shots

World / Science & Health Dec 3, 2021

Six vaccines show promise as boosters, led by mRNA shots

by Suzi Ring and Irina Anghel

Researchers tested the vaccines in more than 2,800 volunteers 30 and older who had already received two doses of the AstraZeneca or Pfizer shots.

Omicron is a wake-up call to fix vaccine inequality

Editorials Dec 3, 2021

Omicron is a wake-up call to fix vaccine inequality

The most important factor in COVID-19's evolution and the threat its variants pose is the size of unvaccinated populations and the reservoirs in which they can develop.

« 1 … 20 21 22 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times